via University of Copenhagen
The receptor responsible for activating the energy-burning property of brown fat in humans has been identified. The next step is to investigate drugs that fit the receptor and trigger the response as a means to treat obesity and type-2 diabetes. The discovery is the result of an international collaboration, including scientists at the University of Copenhagen and Université de Sherbrooke, who published their findings in Cell Metabolism.
An international research team have discovered how to activate brown fat in humans, which may lead to new treatments for type 2 diabetes and obesity. The results of the collaboration between the Centre de recherche du Centre hospitalier universitaire de Sherbrooke (CRCHUS) and the Novo Nordisk Foundation Center for Basic Metabolic Research (CBMR) at the University of Copenhagen were published in Cell Metabolism.
Brown fat burns energy and generates heat – a process called thermogenesis – after being activated by cold temperature or chemical signals. Humans have small deposits of brown fat, and scientists have long hypothesized that finding alternative ways to pharmacologically activate the fat could help improve metabolism.
Scientists have now discovered that beta2-adrenergic receptors (b2-AR) in brown fat cells are responsible for stimulating thermogenesis. According to Dr. Denis Blondin from CRCHUS, the finding could explain why most clinical trials, which have attempted to induce BAT to burn energy, have performed poorly.
“We show that perhaps we were aiming for the wrong target all along. In contrast to rodents, human BAT is activated through the stimulation of the beta2-adrenergic receptor, the same receptor responsible for the release of fat from our white adipose tissue.”
A step toward unlocking the potential of brown fat
According to Associate Professor Camilla Schéele at CBMR, this finding has clear therapeutic applications.
“Activation of brown fat burns calories, improves insulin sensitivity and even affects appetite regulation. Our data reveals a previously unknown key to unlocking these functions in humans, which would potentially be of great gain for people living with obesity or type 2 diabetes”.
A second phase of research will begin in the autumn, which will attempt to validate the finding by activating brown fat with drugs that target b2-AR, explains Professor André Carpentier from CRCHUS:
“Our next step will be to use a drug that specifically activate that target on brown fat and determine how much it could be of use to burn fat and calories in humans. Once this is done, studies in patients with type 2 diabetes will start to determine if this approach can be useful to improve the metabolic control of the disease.”
The international team of scientists responsible for the discovery also include researchers from Leiden University (Netherlands), the Centre for Physical Activity Research at Rigshospitalet (Denmark), the University of Ottawa (Canada), Université Laval (Canada) and Université de Sherbrooke (Canada).
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Who's the fattest? 'Earl of Avoirdupois,' bear 747, beats 'Chunk' in Fat Bear Week 2020 championshipon October 6, 2020 at 7:48 pm
The annual tournament at Katmai National Park asks its social-media followers to vote for the bear that's packed on the most pre-hibernation pounds.
- The Fat Bear Week winner is truly colossalon October 6, 2020 at 7:33 pm
Welcome to Fat Bear Week 2020! Katmai National Park and Preserve’s brown bears spent the summer gorging on 4,500-calorie salmon, and they've transformed into rotund giants, some over 1,000 pounds.
- A champion has been crowned in Fat Bear Weekon October 6, 2020 at 7:12 pm
The votes are in for Katmai National Park’s annual Fat Bear Week tournament and 747 is the champion! There couldn’t have been a more epic matchup than the championship face-off between two aptly named ...
- A Fat Bear Week champion has been crowned: 747 is 2020’s thickest kingon October 6, 2020 at 7:07 pm
After days of battling other corpulent contenders, 747 was crowned 2020’s Fat Bear Week champion, beating 32 “Chunk” in the finals on Fat Bear Tuesday. It’s a fitting victory for the gargantuan ...
- 2 behemoths clash in the Fat Bear Week finalson October 6, 2020 at 9:05 am
Two hugely successful bears will meet in the Fat Bear Week finals on Tuesday, Oct. 6. So exercise the power of your vote! It's colossal bear 747 vs bear 32, "Chunk." Both spent much of their Alaskan ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- beta2-Adrenergic Receptor Activation and Genetic Polymorphisms in Autism: Data from Dizygotic Twinson October 1, 2020 at 5:00 pm
In this study, we identified an association between overstimulation of the β 2-adrenergic receptor by prenatal terbutaline exposure and autism. We found a relative risk of 2.0 and an increased ...
- Prescribing based on genetic differences shows benefit in children, teens with asthmaon September 17, 2020 at 12:05 pm
Participants were randomly assigned to personalized care according to variation in the gene encoding for the beta-2 adrenergic receptor at position 16 (rs1042713; n = 121) or standard care ...
- Which medications in the drug class Beta2-Adrenergic Agonists, Long-Acting are used in the treatment of Chronic Obstructive Pulmonary Disease (COPD)?on September 10, 2020 at 5:00 pm
Beta 2-agonist bronchodilators activate specific beta 2-adrenergic receptors on the surface of smooth muscle cells, which increases intracellular cyclic adenosine monophosphate (cAMP) and smooth ...
- Profile: AstraZeneca PLC (AZN.N)on August 27, 2020 at 5:00 pm
including long-acting muscarinic antagonist (LAMA)/ long-acting beta2-adrenergic receptor agonist (LABA)/ inhaled corticosteroid (ICS). PT010 is composed of glycopyrrolate, formoterol and ...
- Gaetano Santulli, M.D., Ph.D.on September 4, 2019 at 5:30 am
Science Translational Medicine. 2018;10(427):eaar7529. DOI: 10.1126/scitranslmed.aar7529. 96) Mechanistic role of Beta2 adrenergic receptor in glucose homeostasis. Gaetano Santulli (Corresponding ...